2-溴-4-甲氧基苯甲酸 | 74317-85-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-4-甲氧基苯甲酸
• 中文别名: 2-溴-4-甲氧基-苯甲酸
• 英文名称: 2-bromo-4-methoxybenzoic acid
• 英文别名: 2-Brom-4-methoxy-benzoesaeure
• CAS: 74317-85-4
• 化学式: C₈H₇BrO₃
• mdl: MFCD11044843
• 分子量: 231.046
• InChiKey: SEJVMKLJNIKFAF-UHFFFAOYSA-N

物化性质

• 熔点：
  199℃
• 沸点：
  313.6±27.0 °C(Predicted)
• 密度：
  1.625±0.06 g/cm3 (20 ºC 760 Torr)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-4-methoxybenzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-4-methoxybenzoic acid
CAS number: 74317-85-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7BrO3
Molecular weight: 231.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-4-甲氧基苯甲酸 在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.67h， 以100%的产率得到2-bromo-4-methoxybenzoyl chloride
  参考文献：
  名称：

  通过铜-联吡啶催化的α-氨基苄基硼酸酯的分子内偶联，在硼结合的立体中心形成立体反转CC键。

  摘要：

  通过使用具有2,2'-联吡啶的非手性配体的铜催化剂，可以实现与α-（2-卤代苯甲酰基氨基）苄基硼酸酯的对映体分子内Suzuki-Miyaura型偶联，生成3-取代的异吲哚啉酮。在具有高对映体特异性的6-苯基-2,2'-联吡啶配体的存在下，在硼结合的立体碳上带有氢原子的对映体富集的α-氨基苄基硼反应物进行立体反转偶联。在存在简单的2,2'-联吡啶作为配体的情况下，带有完全取代的与硼结合的立体成核中心的α-氨基苄基硼酸酯也给出了3,3-二取代的异吲哚啉酮，具有立体定向的立体化学转化作用。

  DOI：

  10.1002/anie.201914864
• 作为产物：
  描述：

  2-氨基-4-甲氧基苯甲酸 在 氢溴酸 、 溶剂黄146 、 sodium nitrite 、 copper(I) bromide 作用下， 以 水 为溶剂， 以90%的产率得到2-溴-4-甲氧基苯甲酸
  参考文献：
  名称：

  锌催化的对映选择性和非对映选择性形式 [4 + 2] 环加成，涉及两个缺电子伙伴：1-氮杂二烯和硝基烯烃不对称合成哌啶

  摘要：

  我们报告了通过 1-氮杂二烯和硝基烯烃的 [4 + 2] 环加成反应催化不对称合成哌啶。该反应使用地球上丰富的锌作为催化剂，并且具有高度的非对映选择性和区域选择性。一种新型 BOPA 配体 (F-BOPA) 在该过程中具有高反应性和对映选择性。发现与双（恶唑啉）相邻的芳烃上存在邻位取代特别有影响，因为限制了 1-氮杂二烯与路易斯酸的不希望的配位，从而允许反应在较低温度下进行。使用一系列配体进行的一系列次级动力学同位素效应研究暗示了转化的逐步机制，包括亚胺与硝基烯烃的初始迈克尔型加成，然后是环化事件。

  DOI：

  10.1021/jacs.5b00033

文献信息

• [EN] DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS<br/>[FR] OCTAHYDROPYRROLO [3,4-C] PYRROLES DISUBSTITUÉS UTILISÉS COMME MODULATEURS DU RÉCEPTEUR DE L'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2012145581A1

  公开（公告）日：2012-10-26

  Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  描述了二取代的八氢吡咯[3,4-c]吡咯化合物，这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和病况的方法中有用，比如失眠。
• [EN] cGAS ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DU CGAS
  申请人：IMMUNE SENSOR LLC

  公开号：WO2017176812A1

  公开（公告）日：2017-10-12

  Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

  揭示了一种新型化合物的化学式（I），这些化合物是cGAS拮抗剂，涉及到这些化合物的制备方法、包含这些化合物的药物组合物，以及它们在医学治疗中的应用。
• Chiral Phosphoric Acid Catalyzed Asymmetric Ugi Reaction by Dynamic Kinetic Resolution of the Primary Multicomponent Adduct
  作者：Yun Zhang、Yu-Fei Ao、Zhi-Tang Huang、De-Xian Wang、Mei-Xiang Wang、Jieping Zhu

  DOI：10.1002/anie.201600751

  日期：2016.4.18

  Reaction of isonitriles with 3‐(arylamino)isobenzofuran‐1(3H)‐ones in the presence of a catalytic amount of an octahydro (R)‐binol‐derived chiral phosphoric acid afforded 3‐oxo‐2‐arylisoindoline‐1‐carboxamides in high yields with good to high enantioselectivities. An enantioselective Ugi four‐center three‐component reaction of 2‐formylbenzoic acids, anilines, and isonitriles was subsequently developed

  在催化量的八氢（R）-苯酚衍生的手性磷酸存在下，异腈与3-（芳基氨基）异苯并呋喃-1（3 H）-酮反应，得到3-氧代-2-芳基异吲哚啉-1-羧酰胺高收率，对映选择性好。随后开发了2-甲酰基苯甲酸，苯胺和异腈的对映选择性Ugi四中心三组分反应，用于合成相同的杂环。机理研究表明，对映选择性是由主要的Ugi加合物的动态动力学拆分引起的，而不是由C-C键形成过程引起的。所得的杂环产物具有重要的医学重要性。
• [EN] FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONDENSÉS EN TANT QUE MODULATEURS DE RÉCEPTEUR D'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2011050200A1

  公开（公告）日：2011-04-28

  Disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  描述了二取代的3,8-二氮杂双环[4.2.0]辛烷和3,6-二氮杂双环[3.2.0]庚烷化合物，这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和症状的方法中有用，比如失眠。
• [EN] DISUBSTITUTED OCTAHY - DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS<br/>[FR] OCTAHYDROPYRROLO[3,4-C]PYRROLES DISUBSTITUÉS EN TANT QUE MODULATEURS DE RÉCEPTEUR D'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2011050198A1

  公开（公告）日：2011-04-28

  Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  描述了二取代的八氢吡咯并[3,4-c]吡咯化合物，这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和症状的方法中有用，比如失眠。